ALX Oncology

(NASDAQ) ALXO

Current Price$1.99

Market Cap$266.43M

Since IPO (2020)-93%

5 Year-96%

1 Year+313%

1 Month+16%

ALX Oncology Financials at a Glance

Market Cap

$266.43M

Revenue (TTM)

$0.00

Net Income (TTM)

$88.87M

EPS (TTM)

$-1.49

P/E Ratio

-1.33

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$1.99

Volume

1,168,012

Open

$1.99

Price

$1.99

Volume

1,168,012

Open

$1.99

Previous Close

$1.98

Daily Range

$1.95 - $2.02

52-Week Range

$0.40 - $2.66

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$1.99

Volume

1,168,012

Open

$1.99

Previous Close

$1.98

Daily Range

$1.95 - $2.02

52-Week Range

$0.40 - $2.66

ALXO News

Why ALX Oncology Stock Is Skyrocketing Today

Keith SpeightsOct 3, 2023

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ALX Oncology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jason Lettmann, MBA

Website

www.alxoncology.com

Headquarters

South San Francisco, CA 94080, US

ALXO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-74%

Return on Capital

-58%

Return on Assets

-50%

Earnings Yield

-75.19%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$266.43M

Shares Outstanding

134.56M

Volume

1.17M

Avg. Volume

878.44K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$104.02M

EBITDA

$99.39M

Operating Cash Flow

$84.14M

Capital Expenditure

$212.00K

Free Cash Flow

$84.35M

Cash & ST Invst.

$44.79M

Total Debt

$5.22M

ALX Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$150.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$266.43M

N/A

Market Cap/Employee

$4.10M

N/A

Employees

N/A

Net Income

$17.93M

+41.7%

EBITDA

$18.82M

+37.6%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$135.11M

+53.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$5.22M

+200.0%

Return on Assets

-49.83%

N/A

Return on Invested Capital

-57.65%

N/A

Free Cash Flow

$18.70M

+24.4%

Operating Cash Flow

$18.65M

+24.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

STROSutro Biopharma, Inc.

STROSutro Biopharma, Inc.$25.57-16.49%

ARTVArtiva Biotherapeutics, Inc.

ARTVArtiva Biotherapeutics, Inc.$7.87-1.50%

IMUXImmunic, Inc.

IMUXImmunic, Inc.$13.05+6.10%

RPTXRepare Therapeutics Inc.

RPTXRepare Therapeutics Inc.$2.65+0.00%

ADVMAdverum Biotechnologies, Inc.

ADVMAdverum Biotechnologies, Inc.$4.36+0.00%

DTILPrecision BioSciences, Inc.

DTILPrecision BioSciences, Inc.$7.23+1.12%

BMEABiomea Fusion, Inc.

BMEABiomea Fusion, Inc.$1.42+3.65%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

BBBlackBerry

BBBlackBerry$7.91+0.19%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.50-0.01%

Questions About ALXO

What is the current price of ALX Oncology?

ALX Oncology is trading at $1.98 per share.

What is the 52-week range for ALX Oncology?

Over the past 52 weeks, ALX Oncology has traded between $0.40 and $2.66.

How much debt does ALX Oncology have?

As of the most recent reporting period, ALX Oncology reported total debt of $13.05M.

How much cash does ALX Oncology have on hand?

ALX Oncology reported $32.28M in cash and cash equivalents in its most recent financial results.

What is ALX Oncology’s dividend yield?

ALX Oncology does not currently have a dividend yield.

ALX Oncology

ALX Oncology Financials at a Glance

ALXO News

Why ALX Oncology Stock Is Skyrocketing Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ALX Oncology

ALXO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ALX Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALXO

What is the current price of ALX Oncology?

What is the 52-week range for ALX Oncology?

How much debt does ALX Oncology have?

How much cash does ALX Oncology have on hand?

What is ALX Oncology’s dividend yield?

Premium Investing Services